Pharma Journalist -

Boehringer Ingelheim and MiNA Therapeutics (“MiNA”) announced that they have signed a collaboration and licensing agreement focused on the development of novel compounds to treat…
Read More...

Neurimmune announced that it has entered into a collaboration with Ono Pharmaceutical Co., Ltd. focused on the development of human antibodies against a novel therapeutic target for…
Read More...

Valeant Pharmaceuticals International announced that its affiliate has entered into an agreement to divest the Sprout Pharmaceuticals subsidiary ("Sprout") to a buyer affiliated with…
Read More...

In a small safety trial based on preclinical work by a Stanford researcher, participants receiving blood plasma infusions from young donors showed some evidence of improvement.…
Read More...

Spanish pharmaceutical company Almirall opted for Werum’s PAS-X Manufacturing Execution System to be installed in the German plant in Reinbek near Hamburg. Almirall is the market leader…
Read More...

The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare…
Read More...

Millendo Therapeutics announced positive topline results from a Phase 2 proof-of-concept study of ATR-101 in classic congenital adrenal hyperplasia (CAH), a rare inherited endocrine…
Read More...

Torrent Pharmaceuticals Limited and Unichem Laboratories Limited announced that Torrent has entered into a definitive binding agreement with Unichem to acquire its branded business of…
Read More...

PharmaMar has announced a licensing agreement with Boryung Pharm to commercialize the marine-derived anticancer drug Zepsyre (lurbinectedin), if approved, in South Korea. Under the…
Read More...

TherapeuticsMD announced a regulatory update regarding the New Drug Application (NDA) for TX-004HR, the Company’s investigational applicator-free estradiol vaginal softgel capsule for…
Read More...